Commentary examines cardiovascular and performance claims in Tentorium® products, suggesting need for evidence alignment with clinical standards.
Key Points
This commentary assesses the scientific evidence backing cardiovascular and performance claims of honey-based apitherapy products marketed by Tentorium®.
Analysis of publicly available documentation related to Tentorium® products.
Examination of marketed claims against standards for trial registration, outcome reporting, and industry sponsorship disclosure.
No PubMed indexed randomized controlled trials or registry identifiers for Tentorium®'s claims were identified.
Claims related to endurance, recovery, and cardiovascular outcomes were substantiated, but lacked rigorous evidence.
Challenges in evidence transparency and regulatory practices were highlighted in the context of global dietary supplement market.